These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32943543)

  • 1. Synthetic Lethal Metabolic Targeting of Androgen-Deprived Prostate Cancer Cells with Metformin.
    Yang B; Damodaran S; Khemees TA; Filon MJ; Schultz A; Gawdzik J; Etheridge T; Malin D; Richards KA; Cryns VL; Jarrard DF
    Mol Cancer Ther; 2020 Nov; 19(11):2278-2287. PubMed ID: 32943543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
    Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
    Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
    Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
    J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway.
    Sun S; Gong F; Liu P; Miao Q
    Gene; 2018 Jul; 664():50-57. PubMed ID: 29678660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer.
    Kawata H; Kamiakito T; Nakaya T; Komatsubara M; Komatsu K; Morita T; Nagao Y; Tanaka A
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):219-227. PubMed ID: 27329245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration.
    Liu Q; Tong D; Liu G; Gao J; Wang LA; Xu J; Yang X; Xie Q; Huang Y; Pang J; Wang L; He Y; Zhang D; Ma Q; Lan W; Jiang J
    Clin Cancer Res; 2018 Nov; 24(22):5622-5634. PubMed ID: 30012567
    [No Abstract]   [Full Text] [Related]  

  • 7. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C; Liu VW; Chan DW; Yao KM; Ngan HY
    Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer.
    Cui J; Wang Y; Dong B; Qin L; Wang C; Zhou P; Wang X; Xu H; Xue W; Fang YX; Gao WQ
    Int J Cancer; 2018 Aug; 143(3):645-656. PubMed ID: 29488214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway.
    Cai F; Zhang Y; Li J; Huang S; Gao R
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.
    Hessenkemper W; Roediger J; Bartsch S; Houtsmuller AB; van Royen ME; Petersen I; Grimm MO; Baniahmad A
    Mol Endocrinol; 2014 Nov; 28(11):1831-40. PubMed ID: 25203674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo.
    Ewald JA; Desotelle JA; Church DR; Yang B; Huang W; Laurila TA; Jarrard DF
    Prostate; 2013 Mar; 73(4):337-45. PubMed ID: 22911222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Metformin and GANT61 Combinations on the Radiosensitivity of Prostate Cancer Cells.
    Gonnissen A; Isebaert S; McKee CM; Muschel RJ; Haustermans K
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2.
    Pernicová Z; Slabáková E; Kharaishvili G; Bouchal J; Král M; Kunická Z; Machala M; Kozubík A; Souček K
    Neoplasia; 2011 Jun; 13(6):526-36. PubMed ID: 21677876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor β regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3.
    Chaurasiya S; Wu W; Strom AM; Warner M; Gustafsson JÅ
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26347-26355. PubMed ID: 33020300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
    Morell C; Bort A; Vara D; Ramos-Torres A; Rodríguez-Henche N; Díaz-Laviada I
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):248-57. PubMed ID: 27324222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
    Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
    Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin induces apoptosis and inhibits migration by activating the AMPK/p53 axis and suppressing PI3K/AKT signaling in human cervical cancer cells.
    Chen YH; Yang SF; Yang CK; Tsai HD; Chen TH; Chou MC; Hsiao YH
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts.
    Kim K; Watson PA; Lebdai S; Jebiwott S; Somma AJ; La Rosa S; Mehta D; Murray KS; Lilja H; Ulmert D; Monette S; Scherz A; Coleman JA
    Clin Cancer Res; 2018 May; 24(10):2408-2416. PubMed ID: 29463549
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting IKKε in Androgen-Independent Prostate Cancer Causes Phenotypic Senescence and Genomic Instability.
    Gilbert S; Péant B; Malaquin N; Tu V; Fleury H; Leclerc-Desaulniers K; Rodier F; Mes-Masson AM; Saad F
    Mol Cancer Ther; 2022 Mar; 21(3):407-418. PubMed ID: 34965959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.